| scholarly article | Q13442814 |
| P50 | author | James E. Crowe, Jr. | Q37366747 |
| Palani Ramanathan | Q57014329 | ||
| Erica Ollmann Saphire | Q28320547 | ||
| P2093 | author name string | Michelle Meyer | |
| Asuka Yoshida | |||
| Alexander Bukreyev | |||
| Peter L Collins | |||
| Siba Samal | |||
| P2860 | cites work | Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies | Q36208191 |
| Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection | Q36522002 | ||
| Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates | Q36583281 | ||
| Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens | Q36692742 | ||
| Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies | Q36736403 | ||
| Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge | Q37113787 | ||
| Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates | Q37213207 | ||
| The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties | Q37468199 | ||
| The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing | Q37662967 | ||
| Immunodominance of adenovirus-derived CD8(+) T cell epitopes interferes with the induction of transgene-specific immunity in adenovirus-based immunization | Q38645969 | ||
| Newcastle disease virus V protein is a determinant of host range restriction | Q39864222 | ||
| Epitopes required for antibody-dependent enhancement of Ebola virus infection | Q40433095 | ||
| Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening | Q40516689 | ||
| Ectodomain shedding of the glycoprotein GP of Ebola virus | Q40535432 | ||
| Role of fusion protein cleavage site in the virulence of Newcastle disease virus | Q40612116 | ||
| Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury | Q40616926 | ||
| Epitopes involved in antibody-mediated protection from Ebola virus | Q40625468 | ||
| GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases | Q40676410 | ||
| Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus | Q40713530 | ||
| Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation | Q40735127 | ||
| The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer | Q40998883 | ||
| Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia | Q41918936 | ||
| Pathogenesis of experimental Ebola virus infection in guinea pigs | Q44089764 | ||
| High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus | Q44881919 | ||
| The effect on pathogenesis of Newcastle disease virus LaSota strain from a mutation of the fusion cleavage site to a virulent sequence | Q45407619 | ||
| Antigenic and molecular properties of Murayama virus isolated from cynomolgus monkeys: the virus is closely related to avian paramyxovirus type 2. | Q45773051 | ||
| Recent advances in Ebolavirus vaccine development | Q22305433 | ||
| A global approach to HIV-1 vaccine development | Q27024614 | ||
| Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus | Q27339643 | ||
| Ebolavirus glycoprotein structure and mechanism of entry | Q27490991 | ||
| Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light Chain | Q27649064 | ||
| Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor | Q27651112 | ||
| Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus | Q27676230 | ||
| Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection | Q28588877 | ||
| Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus | Q33733844 | ||
| Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic | Q33743800 | ||
| Newcastle disease and other avian paramyxoviruses | Q33997603 | ||
| Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates | Q34092801 | ||
| A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge | Q34434713 | ||
| Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates | Q34651319 | ||
| Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens | Q34982625 | ||
| Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. | Q35299756 | ||
| Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines | Q35635459 | ||
| Successful topical respiratory tract immunization of primates against Ebola virus | Q35857218 | ||
| Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms | Q35955731 | ||
| Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses | Q36040533 | ||
| Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response | Q36190519 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Orthoebolavirus zairense | Q10538943 |
| P304 | page(s) | 1816-1829 | |
| P577 | publication date | 2018-08-01 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors | |
| P478 | volume | 24 |
| Q64087092 | Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs | cites work | P2860 |
Search more.